Vertex Pharmaceuticals | Home
Vertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases.
Vertex Pharmaceuticals | Our Company
Vertex Pharmaceuticals strikes at the core of serious diseases to change people's lives – learn about our mission, values and recognition.
Vertex Pharmaceuticals | Our Science | R&D Pipeline
Vertex Pharmaceuticals is focused on discovering, developing and producing innovative medicines so people with serious diseases can lead better lives.
Vertex Pharmaceuticals | Home
Vertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases.
Vertex Pharmaceuticals | Our Science
At Vertex, we believe "impossible" is just a starting point. We’re not limited by what we’ve done before. We’re leveraging our robust toolkit of technologies and expertise to tackle other serious diseases like cystic fibrosis, sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, pain, type 1 diabetes and more.
Investor Relations | Vertex Pharmaceuticals
The Investor Relations website contains information about Vertex Pharmaceuticals's business for stockholders, potential investors, and financial analysts.
Vertex Pharmaceuticals | Our Company
Vertex Pharmaceuticals strikes at the core of serious diseases to change people's lives – learn about our mission, values and recognition.
Vertex in the UK | Vertex
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. We have had a base in the UK …
Vertex Reports Third Quarter 2024 Financial Results | Vertex ...
Nov 4, 2024 · BOSTON--(BUSINESS WIRE)--Nov. 4, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the third quarter ended September 30, 2024, and raised its full-year product revenue guidance to …
Press Releases - Vertex Pharmaceuticals
BOSTON --(BUSINESS WIRE)--Jan. 17, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2023 financial results on Monday, February 5, 2024 after the financial markets close. The company will host a …